Home » Newsletters » BioWorld

BioWorld

Dec. 12, 2005

View Archived Issues

Stock Winners and Losers For The Week

Public Financing Of Biotechnology: November 2005

Other Financings Of Public Biotechnology Companies:November 2005

Venture Capital And Corporate Investments In Biotechnology Companies: November 2005

"Devil In Details" Of CMS Demo Project For 2006

Money Raised Year To Date

Money Raised By Month

Stock Indexes

BioWorld Stock Report For Public Biotechnology Companies

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
In the clinic for June 12, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Anixa, Beone, Bioinvent, Blossomhill, C4, Cellectis, Climb, Elixiron,...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...